Alpha 2.0
Login Register
» Authors » C J Peters

C J Peters

Explore the profile of C J Peters including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 363
Citations 12512
Followers 0
Related Specialties
Infectious Diseases
Microbiology
Tropical Medicine
Top 10 Co-Authors
T G Ksiazek
P E Rollin
S T Nichol
A S Khan
S R Zaki
P B Jahrling
J N Mills
A Sanchez
Shinji Makino
K T McKee Jr
Published In
J Infect Dis
Am J Trop Med Hyg
J Virol
Emerg Infect Dis
Virology
Affiliations
Soon will be listed here.
Recent Articles
1.
Correction: Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials
Harris A, Butterworth J, Boshier P, Mavroveli S, Vadhwana B, Peters C, et al.
Gastric Cancer . 2024 Aug; 27(6):1350. PMID: 39212828
No abstract available.
2.
An original study assessing biomarker success rate in breast cancer recurrence biomarker research
Savva K, MacKenzie A, Coombes R, Zhifang N, Hanna B, Peters C
BMC Med . 2024 Jul; 22(1):307. PMID: 39075505
Background: Breast cancer is the second most common cause of cancer mortality worldwide. Biomarker discovery has led to advances in understanding molecular phenotyping and thus has a great potential for...
3.
United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2023
Booth M, Clements H, Helbrow J, Baxter M, Bleaney C, Hawkins M, et al.
Clin Oncol (R Coll Radiol) . 2024 Jun; 36(9):e283-e291. PMID: 38876807
No abstract available.
4.
Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials
Harris A, Butterworth J, Boshier P, Mavroveli S, Vadhwana B, Peters C, et al.
Gastric Cancer . 2024 May; 27(4):876-883. PMID: 38761290
Background: Despite its recognized importance, there is currently no reliable tool for surgical quality assurance (SQA) of gastrectomy in surgical oncology. The aim of this study was to develop an...
5.
A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium
Peters C, Ang Y, Ciccarelli F, Coles H, Coleman H, Contino G, et al.
Nat Med . 2023 Dec; 30(1):14-16. PMID: 38114667
No abstract available.
6.
The UK National Oesophagogastric Multidisciplinary Team Meeting: An Initiative From the UK & Ireland Oesophagogastric Group
Booth M, Jones C, Helbrow J, Mansoor W, Peters C, Petty R, et al.
Clin Oncol (R Coll Radiol) . 2023 Apr; 35(7):417-420. PMID: 37069000
No abstract available.
7.
Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice
Morrill J, Peters C, Bettinger G, Palermo P, Smith D, Watts D
Vaccine . 2022 Nov; 40(50):7255-7261. PMID: 36333222
Rift Valley fever virus (RVFV) is an important mosquito-borne pathogen that causes outbreaks of severe disease in people and livestock throughout Africa and the Arabian Peninsula. The development of an...
8.
Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for gastric cancer with peritoneal metastases: A systematic review by the PIPAC UK collaborative
Case A, Prosser S, Peters C, Adams R, Gwynne S
Crit Rev Oncol Hematol . 2022 Oct; 180:103846. PMID: 36257535
Introduction: Gastric cancer with peritoneal metastases (GCPM) carries a poor prognosis. Pressurised Intraperitoneal Aerosolised Chemotherapy (PIPAC) offers pharmacokinetic advantages over intravenous therapy, resulting in higher chemotherapy concentrations in peritoneal deposits,...
9.
Assessment of the Burden of Small Intestinal Bacterial Overgrowth (SIBO) in Patients After Oesophagogastric (OG) Cancer Resection
Savva K, Hage L, Belluomo I, Gummet P, Boshier P, Peters C
J Gastrointest Surg . 2021 Oct; 26(4):924-926. PMID: 34671913
No abstract available.
10.
Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance
Whitacre D, Peters C, Sureau C, Nio K, Li F, Su L, et al.
Hum Vaccin Immunother . 2019 Dec; 16(2):251-268. PMID: 31809638
An effective prophylactic hepatitis B virus (HBV) vaccine has long been available but is ineffective for chronic infection. The primary cause of chronic hepatitis B (CHB) and greatest impediment for...